Effects of antihypertensive drugs on dialysis-resistant hypertension, plasma renin and dopamine betahydroxylase activities, metabolic risk factors and calcium phosphate homeostasis: comparison of metoprolol, alphamethyldopa and clonidine in a cross-over trial.
D003000:Clonidine / Q000009:adverse effects / Q000627:therapeutic use*; D004299:Dopamine beta-Hydroxylase / Q000097:blood; D006801:Humans; D006977:Hypertension, Renal / Q000188:drug therapy*; D007676:Kidney Failure, Chronic / Q000150:complications; D008750:Methyldopa / Q000009:adverse effects / Q000627:therapeutic use*; D008790:Metoprolol / Q000009:adverse effects / Q000627:therapeutic use*; D011412:Propanolamines / Q000627:therapeutic use*; D006435:Renal Dialysis; D012083:Renin / Q000097:blood; D012306:Risk
D011412:Propanolamines; D008750:Methyldopa; D004299:Dopamine beta-Hydroxylase; D012083:Renin; D008790:Metoprolol; D003000:Clonidine